# Cbre Group, Inc.: overview

CBRE · NYSE · CIK 1138118 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbre.md) · [Financials](/companies/cbre/financials.md) · [Filings](/companies/cbre/filings.md) · [Insiders](/companies/cbre/insiders.md)

Latest reported revenue: [$11.41bn](/filings/0001138118-26-000031.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 22, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001138118-26-000031).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [10.2 d](/filings/0001138118-26-000005.md) | [8.8](/filings/0001138118-26-000015.md) | [9.6](/filings/0001138118-26-000024.md) | [10.1](/filings/0001138118-26-000031.md) | [11.4 d](/filings/0001138118-26-000005.md) | [10.4](/filings/0001138118-26-000015.md) | [11.1](/filings/0001138118-26-000024.md) | [11.4](/filings/0001138118-26-000031.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [5.8% d](/filings/0001138118-26-000005.md) | [3.1%](/filings/0001138118-26-000015.md) | [3.9%](/filings/0001138118-26-000024.md) | [4.8%](/filings/0001138118-26-000031.md) | [5.4% d](/filings/0001138118-26-000005.md) | [4.9%](/filings/0001138118-26-000015.md) | [3.3%](/filings/0001138118-26-000024.md) | [4.9%](/filings/0001138118-26-000031.md) |
| Net margin | % | [4.8% d](/filings/0001138118-26-000005.md) | [1.9%](/filings/0001138118-26-000015.md) | [2.2%](/filings/0001138118-26-000024.md) | [3.6%](/filings/0001138118-26-000031.md) | [3.6% d](/filings/0001138118-26-000005.md) | [3.1%](/filings/0001138118-26-000015.md) | [1.8%](/filings/0001138118-26-000024.md) | [3.9%](/filings/0001138118-26-000031.md) |
| Diluted EPS | $ per share | not reported | [0.54](/filings/0001138118-26-000015.md) | [0.72](/filings/0001138118-26-000024.md) | [1.21](/filings/0001138118-26-000031.md) | not reported | [1.07](/filings/0001138118-26-000015.md) | [0.69](/filings/0001138118-26-000024.md) | [1.52](/filings/0001138118-26-000031.md) |
| Free cash flow | $bn | [1.2 d](/filings/0001138118-26-000005.md) | [(0.6)](/filings/0001138118-26-000015.md) | [(0.0) d](/filings/0001138118-26-000024.md) | [0.7 d](/filings/0001138118-26-000031.md) | [1.1 d](/filings/0001138118-26-000005.md) | [(0.9)](/filings/0001138118-26-000015.md) | [0.0 d](/filings/0001138118-26-000024.md) | [0.7 d](/filings/0001138118-26-000031.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [27.0](/filings/0001138118-24-000006.md) | [30.2](/filings/0001138118-25-000005.md) | [31.5](/filings/0001138118-26-000005.md) | [35.2](/filings/0001138118-26-000005.md) | [39.9](/filings/0001138118-26-000005.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [6.1%](/filings/0001138118-24-000006.md) | [5.0%](/filings/0001138118-25-000005.md) | [3.5%](/filings/0001138118-26-000005.md) | [4.0%](/filings/0001138118-26-000005.md) | [4.4%](/filings/0001138118-26-000005.md) |
| Net margin | % | [6.8%](/filings/0001138118-24-000006.md) | [4.7%](/filings/0001138118-25-000005.md) | [3.1%](/filings/0001138118-26-000005.md) | [2.8%](/filings/0001138118-26-000005.md) | [2.9%](/filings/0001138118-26-000005.md) |
| Diluted EPS | $ per share | [5.41](/filings/0001138118-24-000006.md) | [4.29](/filings/0001138118-25-000005.md) | [3.15](/filings/0001138118-26-000005.md) | [3.14](/filings/0001138118-26-000005.md) | [3.85](/filings/0001138118-26-000005.md) |
| Free cash flow | $bn | [2.2](/filings/0001138118-24-000006.md) | [1.4](/filings/0001138118-25-000005.md) | [0.2](/filings/0001138118-26-000005.md) | [1.4](/filings/0001138118-26-000005.md) | [1.2](/filings/0001138118-26-000005.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cbre/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.73bn | 27,714,625 |  | Reduced −41,849 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $3.48bn | 25,843,839 |  | Added +36,289 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.58bn | 19,136,858 |  | Added +85,839 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.93bn | 14,315,011 |  | Added +298,532 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $1.38bn | 10,244,499 |  | Added +374,086 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.14bn | 8,527,543 |  | Reduced −101,295 |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $810.0m | 6,013,890 |  | Reduced −408,300 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $781.2m | 5,799,978 |  | Reduced −494,069 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $754.4m | 5,601,115 |  | Added +963,259 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $688.1m | 5,056,217 |  | Reduced −122,857 |

## Recent filings

[All 1,899 filings](/companies/cbre/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:13 ET | [8-K](/filings/0001193125-26-436371.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-436371 |
| 2026-10-22 | 16:41 ET | [10-Q](/filings/0001138118-26-000031.md) | Quarterly report, period 2026-09-30 | 0001138118-26-000031 |
| 2026-10-22 | 07:03 ET | [8-K](/filings/0001138118-26-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001138118-26-000028 |
| 2026-10-20 | 17:04 ET | [8-K](/filings/0001193125-26-426827.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-426827 |
| 2026-07-29 | 16:42 ET | [10-Q](/filings/0001138118-26-000024.md) | Quarterly report, period 2026-06-30 | 0001138118-26-000024 |
| 2026-07-29 | 07:02 ET | [8-K](/filings/0001138118-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001138118-26-000021 |
| 2026-06-23 | 17:08 ET | [8-K](/filings/0001193125-26-279756.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-279756 |
| 2026-06-15 | 17:28 ET | [8-K](/filings/0001193125-26-271325.md) | 7.01 Regulation FD disclosure | 0001193125-26-271325 |
| 2026-05-22 | 17:00 ET | [8-K](/filings/0001193125-26-237130.md) | 5.07 Shareholder vote results | 0001193125-26-237130 |
| 2026-05-04 | 17:00 ET | [8-K](/filings/0001193125-26-204246.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-204246 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001138118-26-000005.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1138118
- Tickers: CBRE
- Exchange: NYSE
- SIC code: 6500 Real Estate
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:34 ET. No prices; not investment advice.